Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform 2025-10-29 23:15
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences 2025-10-17 15:21
Everest Medicines Expands Strategic Investment in I-MAB 2025-08-01 21:02
I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member 2025-01-08 20:00
I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program 2025-01-06 20:00
I-Mab to Participate at the Piper Sandler Healthcare Conference 2024-11-21 20:00
I-Mab Reports Third Quarter 2024 Results 2024-11-14 20:00
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer 2024-11-06 20:00
I-Mab to Release Q3 2024 Financial Results on November 14, 2024 2024-10-31 19:00
I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024 2024-10-30 19:00
I-Mab to Participate at the Truist Securities BioPharma Symposium 2024-10-28 19:00
I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer 2024-09-10 19:00
I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference 2024-08-26 19:00
I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC) 2024-08-07 19:00
I-Mab Announces Leadership Transitions 2024-07-15 19:30
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer 2024-06-06 19:00
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers 2024-06-05 19:00
I-Mab to Participate at the Jefferies Global Healthcare Conference 2024-05-22 19:00
I-MAB Filed 2023 Annual Report on Form 20-F 2024-04-30 19:00
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference 2024-04-05 19:00
1 2 3 4 5 8